Yale University

Cost-effectiveness analysis of brief and expanded evidence-based risk reduction interventions for HIV-infected people who inject drugs in the United States.

TitleCost-effectiveness analysis of brief and expanded evidence-based risk reduction interventions for HIV-infected people who inject drugs in the United States.
Publication TypeJournal Article
Year of Publication2015
AuthorsSong, Dahye L., Frederick L. Altice, Michael M. Copenhaver, and Elisa F. Long
JournalPloS one
Volume10
Issue2
Paginatione0116694
Date Published2015
ISSN1932-6203
KeywordsAdolescent, Adult, Costs and Cost Analysis, Female, HIV Infections, HIV-1, Humans, Male, Middle Aged, Prevalence, Retrospective Studies, Substance-Related Disorders, United States
AbstractTwo behavioral HIV prevention interventions for people who inject drugs (PWID) infected with HIV include the Holistic Health Recovery Program for HIV+ (HHRP+), a comprehensive evidence-based CDC-supported program, and an abbreviated Holistic Health for HIV (3H+) Program, an adapted HHRP+ version in treatment settings. We compared the projected health benefits and cost-effectiveness of both programs, in addition to opioid substitution therapy (OST), to the status quo in the U.S.
DOI10.1371/journal.pone.0116694
Alternate JournalPLoS ONE

External Links